Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of the VIS4ION Platform and Assistive Tactile and Auditory Communicating Devices in Low Vision Subjects

NCT03174314 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03174314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03174314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of the VIS4ION Platform and Assistive Tactile and Auditory Communicating Devices in Low Vision Subjects
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
July 26, 2017
Completion date
July 23, 2024
Enrollment
120 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

visual impairment